Literature DB >> 10203530

Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans.

O Kurzai1, W J Heinz, D J Sullivan, D C Coleman, M Frosch, F A Mühlschlegel.   

Abstract

The development of a satisfactory means to reliably distinguish between the two closely related species Candida albicans and Candida dubliniensis in the clinical mycology laboratory has proved difficult because these two species are phenotypically so similar. In this study, we have detected homologues of the pH-regulated C. albicans PHR1 and PHR2 genes in C. dubliniensis. Restriction fragment length polymorphism analysis suggests that there are significant sequence differences between the genes of the two species. In order to exploit this apparent difference, oligonucleotide primers based on the coding sequence of the C. albicans PHR1 structural gene were designed and used in PCR experiments. Use of these primers with C. albicans template DNA from 17 strains yielded a predicted 1.6-kb product, while C. dubliniensis template DNA from 19 strains yielded no product. We therefore propose that PCR using these primers is a rapid and reliable means of distinguishing the two germ tube- and chlamydospore-producing species C. albicans and C. dubliniensis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203530      PMCID: PMC84840     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  PHR2 of Candida albicans encodes a functional homolog of the pH-regulated gene PHR1 with an inverted pattern of pH-dependent expression.

Authors:  F A Mühlschlegel; W A Fonzi
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.

Authors:  A Schoofs; F C Odds; R Colebunders; M Ieven; H Goossens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

Review 3.  Candidiasis: the emergence of a novel species, Candida dubliniensis.

Authors:  D C Coleman; D J Sullivan; D E Bennett; G P Moran; H J Barry; D B Shanley
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

4.  Isolation and deduced amino acid sequence of the gene encoding gp115, a yeast glycophospholipid-anchored protein containing a serine-rich region.

Authors:  M Vai; E Gatti; E Lacanà; L Popolo; L Alberghina
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

5.  Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.

Authors:  G P Moran; D J Sullivan; M C Henman; C E McCreary; B J Harrington; D B Shanley; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals.

Authors:  D Sullivan; K Haynes; J Bille; P Boerlin; L Rodero; S Lloyd; M Henman; D Coleman
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

Review 7.  Candida dubliniensis: characteristics and identification.

Authors:  D Sullivan; D Coleman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

8.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

9.  Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.

Authors:  P J Gallagher; D E Bennett; M C Henman; R J Russell; S R Flint; D B Shanley; D C Coleman
Journal:  J Gen Microbiol       Date:  1992-09

Review 10.  Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities.

Authors:  S E Reef; K H Mayer
Journal:  Clin Infect Dis       Date:  1995-08       Impact factor: 9.079

View more
  24 in total

1.  Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections.

Authors:  J Xu; B C Millar; J E Moore; R McClurg; M J Walker; J Evans; S Hedderwick; R McMullan
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

2.  Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies.

Authors:  Agnes Marot-Leblond; Bertrand Beucher; Sandrine David; Sandrine Nail-Billaud; Raymond Robert
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Prevalence of Candida dubliniensis fungemia in Argentina: identification by a novel multiplex PCR and comparison of different phenotypic methods.

Authors:  Maria Eugenia Bosco-Borgeat; Constanza Giselle Taverna; Susana Cordoba; Maria Guillermina Isla; Omar Alejandro Murisengo; Wanda Szusz; Walter Vivot; Graciela Davel
Journal:  Mycopathologia       Date:  2011-07-13       Impact factor: 2.574

4.  Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.

Authors:  Sarah F Gee; Sophie Joly; David R Soll; Jacques F G M Meis; Paul E Verweij; Itzhack Polacheck; Derek J Sullivan; David C Coleman
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis.

Authors:  A Borst; B Theelen; E Reinders; T Boekhout; A C Fluit; P H M Savelkoul
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes.

Authors:  K Oliveira; G Haase; C Kurtzman; J J Hyldig-Nielsen; H Stender
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

7.  Amplification of the hyphal wall protein 1 gene to distinguish Candida albicans from Candida dubliniensis.

Authors:  Orazio Romeo; Cosimo Racco; Giuseppe Criseo
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

8.  Comparison of VITEK 2 with ITS2-fragment length polymorphism analysis for identification of yeast species.

Authors:  Caroline Massonet; Johan Van Eldere; Mario Vaneechoutte; Thierry De Baere; Jan Verhaegen; Katrien Lagrou
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.

Authors:  Stavroula Antonopoulou; Michel Aoun; Evangelos C Alexopoulos; Stavroula Baka; Emanuel Logothetis; Theodoros Kalambokas; Andreas Zannos; Konstantine Papadias; Odysseas Grigoriou; Evangelia Kouskouni; Aristea Velegraki
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

10.  Differentiation of Candida dubliniensis from Candida albicans on rosemary extract agar and oregano extract agar.

Authors:  Erico Silva de Loreto; Patrícia Pozzatti; Liliane Alves Scheid; Deise Santurio; Janio Morais Santurio; Sydney Hartz Alves
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.